Timothy J. Hobday

Also affiliated with Emory University, WinnMed, Mayo Clinic in Arizona

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer”.

Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer

JAMA Oncology(2023)10.1001/jamaoncol.2022.7949

N/A

1.4DataRank · unranked

52 citations

Vera J. Suman, Antonino B. D’Assoro, Jodi M. Carter, Karthik V. Giridhar, Brendan P. McMenomy +18 more

TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer

UNC Libraries(2020)10.17615/yrss-qx89

N/A

0DataRank · unranked

0 citations

Charles M. Perou, Madlyn Ferraro, Mothaffar F. Rimawi, Wing‐Keung Chiu, Antonio C. Wolff +15 more

Clinical Management of Metastatic Hormone Receptor-Positive, HER2-negative Breast Cancer (MBC) After CDK 4/6 inhibitors: A Retrospective Single-Institution Study

Research Square(2022)10.21203/rs.3.rs-1601792/v1

N/A

0DataRank · unranked

0 citations

S. Liddell, Roberto A. Leon‐Ferre, Ciara C. O’Sullivan, Kathryn J. Ruddy, Tufia C. Haddad +6 more

Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad096

N/A

0DataRank · unranked

9 citations

Thomas A. Hope, Emily B Bergsland, Lisa Bodei, David Bushnell, Jennifer A. Chan +63 more

Efficacy of first‐line checkpoint inhibitors in combination with chemotherapy in high‐grade extrapulmonary metastatic neuroendocrine carcinomas

Journal of Neuroendocrinology(2023)10.1111/jne.13283

N/A

0DataRank · unranked

1 citations

Patrick W. McGarrah, Konstantinos Leventakos, Mohamad Bassam Sonbol, Jason S. Starr, Rachel A. Eiring +3 more

Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0341

N/A

0DataRank · unranked

4 citations

Vera J. Suman, Karthik V. Giridhar, Kostandinos Sideras, Donald W. Northfelt, Brenda Ernst +15 more